We are developing CAD that Works® to empower radiologists, support their patients and reduce costs while improving clinical outcomes.
Location: United States, California, San Diego
Employees: 11-50
Phone: +1 619-339-9889
Founded date: 2014
Investors 3
Mentions in press and media 23
| Date | Title | Description |
| 01.09.2026 | Suffolk Breast Imaging Redefines Routine Mammography with CureMetrix's cmAngio® | Long Island breast imaging practice enhances routine screening mammography with AI-powered Breast Arterial Calcification detection At Suffolk Breast Imaging, we've always believed that combining experienced breast imaging specialists with a... |
| 17.08.2026 | FDA Clears CureMetrix's cmAngio 2.0, Introducing BAC Quantification and Age-Based Context | New release introduces BAC quantification, age-based context, enhanced reporting, and seamless integration. cmAngio 2.0 represents a seismic shift in the depth of information physicians now have to drive meaningful conversations with their ... |
| 20.07.2026 | Breast Center of New England Expands Personalized Breast Imaging Services with CureMetrix’s cmAngio® | CureMetrix Logo Breast Center of New England Logo Boutique breast imaging practice adds AI Breast Arterial Calcification detection to provide additional clinical insight from routine screening mammograms. From the beginning, our goal has be... |
| 06.07.2026 | Invision Diagnostics Expands Women's Health Offerings with CureMetrix's cmAngio® | CureMetrix Logo Invision Diagnostics Logo CureMetrix and Invision Diagnostics are expanding access to AI-powered breast imaging by bringing cmAngio® to mobile mammography services. Adding cmAngio to our offerings supports providers with add... |
| 16.04.2026 | CureMetrix and Cascaid Health Announce Collaboration to Support Coordination Following Radiologist‑Reviewed BAC Findings | CureMetrix Logo Cascaid Health Updated SAN DIEGO, CA, UNITED STATES, April 16, 2026 /EINPresswire.com/ -- CureMetrix, the first and only company with FDA‑cleared technology to detect breast arterial calcifications (BAC) on mammograms, and C... |
| 03.02.2026 | CureMetrix® Brings cmAngio® BAC Detection to Rezolut Imaging Patients | Extends routine mammography to deliver a “2-for-1” exam, screening for breast cancer and breast arterial calcifications in one study. By incorporating CureMetrix’s cmAngio into our imaging network, we are expanding the role of mammography b... |
| 03.11.2025 | CureMetrix joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation | CureMetrix Logo American Heart Association consortium advances development of evidence-based health tech solutions Being part of this network of innovators allows us to collaborate with organizations that share our vision for advancing heal... |
| 15.04.2025 | CureMetrix Expands cmAngio With FDA Clearance for Version 1.6, Now Validated on Hologic & GE Platforms | CureMetrix expands FDA clearance for cmAngio to include GE Healthcare, increasing access for more women to AI-powered BAC detection in mammography. SAN DIEGO, CA, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- CureMetrix®, a global lea... |
| 05.02.2025 | CureMetrix and Volpara Health x Lunit Enter Agreement to Expand Access to cmAngio | Enhancing Women's Health: CureMetrix cmAngio is now available to thousands of providers through Volpara SAN DIEGO, CA, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- CureMetrix®, a leader in AI-based solutions for mammography, announ... |
| 28.01.2025 | CureMetrix Receives Medical Device Single Audit Program (MDSAP) Certification | CureMetrix Achieves MDSAP Certification, Reinforcing Commitment to safety, compliance and accelerating the global expansion of AI-based women’s health solutions SAN DIEGO, CA, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- CureMetrix... |
Show more